Development and validation of DSTOX: an integrated QSAR platform adhering to ICH M7 guidelines for mutagenicity assessment of drug impurities

Guo Yu, Tiantian Xu, Siyao Fan, Zejian Zhou, Jinqi Zheng

Open source

DOI
10.15212/amm-2026-0033
Published
2026
Container
Acta Materia Medica
Publisher
Compuscript, Ltd.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.15212/amm-2026-0033,
  title = {Development and validation of DSTOX: an integrated QSAR platform adhering to ICH M7 guidelines for mutagenicity assessment of drug impurities},
  author = {Guo Yu and Tiantian Xu and Siyao Fan and Zejian Zhou and Jinqi Zheng},
  year = {2026},
  journal = {Acta Materia Medica},
  doi = {10.15212/amm-2026-0033},
  url = {https://doi.org/10.15212/amm-2026-0033}
}

RIS

TY  - JOUR
TI  - Development and validation of DSTOX: an integrated QSAR platform adhering to ICH M7 guidelines for mutagenicity assessment of drug impurities
AU  - Guo Yu
AU  - Tiantian Xu
AU  - Siyao Fan
AU  - Zejian Zhou
AU  - Jinqi Zheng
PY  - 2026
JO  - Acta Materia Medica
DO  - 10.15212/amm-2026-0033
UR  - https://doi.org/10.15212/amm-2026-0033
ER  - 

APA

Yu, G., Xu, T., Fan, S., Zhou, Z., & Zheng, J. (2026). Development and validation of DSTOX: an integrated QSAR platform adhering to ICH M7 guidelines for mutagenicity assessment of drug impurities. Acta Materia Medica. https://doi.org/10.15212/amm-2026-0033

Source records